RING TRI-AD 900SFC26

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,l report with the FDA on 2020-03-19 for RING TRI-AD 900SFC26 manufactured by Medtronic Heart Valves Division.

Event Text Entries

[184174299] Citation: jung w et al. Early clinical outcomes of tricuspid valve repair with a tri-ad annuloplasty ring in comparison with the outcomes using an mc3 ring. Korean j thorac cardiovasc surg. 2018 apr;51(2):92-99. Doi: 10. 5090/kjtcs. 2018. 51. 2. 92. Epub 2018 apr 5. Earliest date of publish used for event date and death date. No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported. Without return of the product no definitive conclusion can be made regarding the clinical observations. If information is provided in the future, a supplemental report will be issued.
Patient Sequence No: 1, Text Type: N, H10


[184174300] Medtronic received information via literature regarding a comparison of the early outcomes in patients who underwent tricuspid valve annuloplasty with a tri-ad ring or an mc3 ring. All data were retrospectively collected from a single center between january 2007 and march 2017. The study population included 229 patients and was predominantly male with a mean age of 59 years. Of those, 36 were implanted with medtronic tri-ad annuloplasty rings. No serial numbers were provided. Among all tri-ad patients, one operative death occurred due to unidentified bleeding and hypovolemic shock. Based on the available information, medtronic product may have been associated with the death. Among all tri-ad patients, adverse events included: reoperation due to bleeding, low cardiac output syndrome, stroke, atrial fibrillation, moderate-severe pulmonary hypertension, mild-moderate-severe tricuspid regurgitation, and moderate-severe left ventricle dysfunction (left ventricular ejection fraction less than 40%). Based on the available information, medtronic product was associated with the adverse events. No additional adverse patient effects or product performance issues were reported.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2025587-2020-00864
MDR Report Key9856621
Report SourceFOREIGN,HEALTH PROFESSIONAL,L
Date Received2020-03-19
Date of Report2020-03-19
Date of Event2018-04-05
Date Mfgr Received2020-02-25
Date Added to Maude2020-03-19
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag0
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactPAULA BIXBY
Manufacturer Street8200 CORAL SEA STREET NE
Manufacturer CityMOUNDS VIEW MN 55112
Manufacturer CountryUS
Manufacturer Postal55112
Manufacturer Phone7635055378
Manufacturer G1MEDTRONIC HEART VALVES DIVISION
Manufacturer Street1851 E DEERE AVE
Manufacturer CitySANTA ANA CA 92705
Manufacturer CountryUS
Manufacturer Postal Code92705
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameRING TRI-AD 900SFC26
Generic NameRING, ANNULOPLASTY
Product CodeKRH
Date Received2020-03-19
Model Number900SFC26
Catalog Number900SFC26
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerMEDTRONIC HEART VALVES DIVISION
Manufacturer Address1851 E DEERE AVE SANTA ANA CA 92705 US 92705


Patients

Patient NumberTreatmentOutcomeDate
101. Death 2020-03-19

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.